Programmbereich Chronische Lungenerkrankungen

DZL Labor Experimentelle Mikrobiomforschung

Mission    Projekte    Drittmittel    Methoden    Publikationen    Mitarbeiter/innen

Publikationen

2023

Chen, J, Wang, X, Schmalen, A, Haines, S, Wolff, M, Ma, H, Zhang, H, Stoleriu, MG, Nowak, J, Nakayama, M, Bueno, M, Brands, J, Mora, AL, Lee, JS, Krauss-Etschmann, S, Dmitrieva, A, Frankenberger, M, Hofer, TP, Noessner, E, Moosmann, A, Behr, J, Milger, K, Deeg, CA, Staab-Weijnitz, CA, Hauck, SM, Adler, H, Goldmann, T, Gaede, KI, Behrends, J, Kammerl, IE & Meiners, S 2023, 'Antiviral CD8+ T cell immune responses are impaired by cigarette smoke and in COPD', The European respiratory journal, Jg. 62, Nr. 2, 2201374. https://doi.org/10.1183/13993003.01374-2022

GEN-COVID Multicenter Study Group 2023, 'CYP19A1 mediates severe SARS-CoV-2 disease outcome in males', Cell reports. Medicine, S. 101152. https://doi.org/10.1016/j.xcrm.2023.101152

 

2022

Ehrhardt, B, Krauss-Etschmann, S, Schramm, J, Kovacevic, D, El-Merhie, N, Roeder, T & Bossen, J 2022, 'Airway remodeling: The Drosophila model permits a purely epithelial perspective', Frontiers in Allergy, Jg. 3, S. 876673. https://doi.org/10.3389/falgy.2022.876673

Pfeiffer, S, Jatzlauk, G, Lund, JV, Boateng, E, Kovacevic, D, N Hylkema, M, Bartel, S, Schloter, M & Krauss-Etschmann, S 2022, 'Oral application of vancomycin alters murine lung microbiome and pulmonary immune responses', Immunity, inflammation and disease, Jg. 10, Nr. 8, S. e675. https://doi.org/10.1002/iid3.675

 

2020

Lund, J, Kovacevic, D, Schloter, M & Krauss-Etschmann, S 2020, 'Rolle der mikrobiellen Darm-Lungen-Achse für die Lungengesundheit: Mikrobiom – Darm-Lungen-Achse – Lungenerkrankungen – bakterielle Metabolite', Pädiatrische Praxis, Jg. 93 / 3, S. 444-452.

Pfeiffer, S, Herzmann, C, Gaede, KI, Kovacevic, D, Krauss-Etschmann, S & Schloter, M 2021, 'Different responses of the oral, nasal and lung microbiomes to cigarette smoke', Thorax. https://doi.org/10.1136/thoraxjnl-2020-216153